112
Views
18
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Hodgkin lymphoma in very young children: Clinical characteristics and outcome of treatment

, , , , &
Pages 910-916 | Received 24 Oct 2007, Accepted 22 Jan 2008, Published online: 01 Jul 2009

References

  • Surveillance Epidemiology and End Result (SEER) Hodgkin Lymphoma fact sheet; [cited 7 July 2007]. Available online: http://seer.cancer.gov/csr/1975_2003/results_merged/sect_09_hodgkins.pdf
  • Clavel J, Steliarova-Foucher E, Berger C, Danon S, Valerianova Z. Hodgkin's disease incidence and survival in European children and adolescents (1978 – 1997): report from the Automated Cancer Information System project. Eur J Cancer 2006; 42: 2037–2049
  • Gruffermann S, Delzell E. Epidemiology of Hodgkin Disease. Epidemiol Rev 1984; 6: 76–106
  • Dinand V, Arya L S. Epidemiology of childhood Hodgkin's disease: is it Different in developing countries?. Indian Pediatr 2006; 43: 141–147
  • Siddiqui N, Ayub B, Badar F, Zaidi A. Hodgkin's lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore. Asian Pac J Cancer Prev 2006; 7: 651–655
  • Stiller C A, Parkin D M. International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol 1990; 4: 303–324
  • Kusuda M, Toriyama K, Kamidigo N O, Itakura H. A comparison of epidemiologic, histologic and virologic studies on Hodgkin's disease in Western Kenya and Nagasaki, Japan. Am J Trop Hyg 1998; 59: 801–817
  • Karimi M, Yarmohammadi H, Ghavanini A A, Kumar P V. Epidemiological surveillance of pediatric Hodgkin's disease in Southern Iran. Med Sci Monit 2002; 8: CR572–CR575
  • Macfarlane G J, Evstifeeva T, Boyle P, Grufferman S. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 1995; 61: 165–169
  • Buyukpamukcu M, Atahan L, Caglar M, Kutluk T, Akyuz C, Hazar V. Hodgkin's disease in Turkish children: clinical characteristics and treatment results of 210 patients. Pediatr Hematol Oncol 1999; 16: 119–129
  • Schwartz C L. The management of Hodgkin disease in the young child. Curr Opin Pediatr 2003; 15: 10–16
  • Chow L ML, Nathan P C, Hodgson D C, Jenkin D, Weitzman S, Grant R M, et al. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. J Clin Oncol 2006; 24: 5735–5741
  • Kung F H. Hodgkin's disease in children 4 years of age or younger. Cancer 1991; 67: 1428–1430
  • Stoneham S, Ashley S, Pinkerton R, Hewitt M, Wallace W HB, Shankar A G. Hodgkin lymphoma in children aged 5 years or less – the United Kingdom experience. Eur J Cancer 2007; 43: 1415–1421
  • Grufferman S, Delzell E. Epidemiology of Hodgkin's disease. Epidemiologic Rev 1984; 6: 76–106
  • Parkin D M, Stiller C A, Draper G J, Bieber C A. The International incidence of childhood cancer. Int J Cancer 1988; 42: 511–520
  • Yadav M S, Malliga N, Ablashi D V. Development of immunity to Epstein – Barr virus in Malaysian children. Microbiologica 1987; 10: 29–35
  • Chan C W, Chiang A KS, Chan K H, Lau A SY. Epstein – Barr virus-associated infectious mononucleosis in Chinese children. Pediatr Infect Dis J 2003; 22: 974–978
  • Murray P G, Billingham L J, Hassan H T, Flavell J R, Nelson P N, Scott K, et al. Effect of Epstein – Barr virus on the response to chemotherapy and survival in Hodgkin's disease. Blood 1999; 94: 442–447
  • Engel M, Essop M F, Close P, Hartley P, Pallesen G, Sinclair-Smith C. Improved prognosis on Epstein – Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases. J Clin Pathol 2000; 53: 182–186
  • Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P. Successful ambulatory treatment of Hodgkin's disease in Iranian children based on German-Austrian DAL-HD 85-90:single institution results. Ann Oncol 2005; 16: 1936–1940
  • Hsu S C, Metzger M L, Hudson M M, Pedrosa F, Lins M, Pedrosa M, et al. Comparison on treatment outcomes on childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Pediatr Blood Cancer 2007; 49: 139–144

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.